NCT01376115View on ClinicalTrials.gov

Drug Use Investigation for ARRANON G (Nelarabine) Injection 250mg

CompletedOBSERVATIONAL
Enrollment

343

Participants

Timeline

Start Date

January 18, 2008

Primary Completion Date

October 24, 2017

Study Completion Date

October 24, 2017

Conditions
Cancer
Interventions
DRUG

Nelarabine

Trial Locations (1)

Unknown

University of Tsukuba Hospital, Tsukuba

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY